FibroBiologics Free Cash Flow (FCF) History (FBLG)

FibroBiologics reported −$16.7M in free cash flow for fiscal 2025, a decrease of $4.6M from the previous fiscal year.

View full FibroBiologics company overview

FibroBiologics free cash flow by year

FibroBiologics annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20252025-12-31−$16.7M−$4.6M
20242024-12-31−$12.1M−$5.2M
20232023-12-31−$6.9M

FibroBiologics free cash flow growth trends

FibroBiologics's latest reported quarter, Q2 2026, generated −$3.3M in free cash flow, an increase of $906,000 year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review FibroBiologics source filings ↗

Community posts

It’s quiet here.

No posts about FBLG yet. Start the conversation.

Write the first post